The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of circulating tumor cells (CTCs) and clinical biomarker endpoints in metastatic prostate cancer patients.
Robert J. Amato
No relevant relationships to disclose
Vladislava O. Melnikova
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Yujian Zhang
Employment or Leadership Position - ApoCell
Wen Liu
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Yuan Wang
Employment or Leadership Position - ApoCell
Parth K. Shah
No relevant relationships to disclose
Brett T Jensen
No relevant relationships to disclose
Karen E. Torres
No relevant relationships to disclose
Darren W. Davis
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell